[ 64 Cu]Cu-PEG-FUD peptide for noninvasive and sensitive detection of murine pulmonary fibrosis
Open Access
- 12 April 2024
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (15) , eadj1444
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease resulting in irreversible scarring within the lungs. However, the lack of biomarkers that enable real-time assessment of disease activity remains a challenge in providing efficient clinical decision-making and optimal patient care in IPF. Fibronectin (FN) is highly expressed in fibroblastic foci of the IPF lung where active extracellular matrix (ECM) deposition occurs. Functional upstream domain (FUD) tightly binds the N-terminal 70-kilodalton domain of FN that is crucial for FN assembly. In this study, we first demonstrate the capacity of PEGylated FUD (PEG-FUD) to target FN deposition in human IPF tissue ex vivo. We subsequently radiolabeled PEG-FUD with 64 Cu and monitored its spatiotemporal biodistribution via μPET/CT imaging in mice using the bleomycin-induced model of pulmonary injury and fibrosis. We demonstrated [ 64 Cu]Cu-PEG-FUD uptake 3 and 11 days following bleomycin treatment, suggesting that radiolabeled PEG-FUD holds promise as an imaging probe in aiding the assessment of fibrotic lung disease activity.Keywords
This publication has 72 references indexed in Scilit:
- Fibronectin-targeted FUD and PEGylated FUD peptides for fibrotic diseasesJournal of Controlled Release, 2023
- Multimodal imaging demonstrates enhanced tumor exposure of PEGylated FUD peptide in breast cancerJournal of Controlled Release, 2022
- [68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activityEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Protective effects of curcumin on bleomycin-induced changes in lung glycoproteinsMolecular and Cellular Biochemistry, 2020
- Characterization of the PEGylated Functional Upstream Domain Peptide (PEG-FUD): a Potent Fibronectin Assembly Inhibitor with Potential as an Anti-Fibrotic TherapeuticPharmaceutical Research, 2018
- Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF)European Journal of Nuclear Medicine and Molecular Imaging, 2018
- Disruption of fibronectin matrix affects type IV collagen, fibrillin and laminin deposition into extracellular matrix of human trabecular meshwork (HTM) cellsExperimental Eye Research, 2017
- Inhibition of fibronectin deposition improves experimental liver fibrosisJournal of Hepatology, 2015
- The N-terminal 70-kDa fragment of fibronectin binds to cell surface fibronectin assembly sites in the absence of intact fibronectinMatrix Biology, 2006
- Actions of the functional upstream domain of protein F1 of Streptococcus pyogenes on the conformation of fibronectinBiophysical Chemistry, 2004